Jim Cramer Smells Opportunity in Biopharma

"If you're going to speculate on biopharma stocks, ideally you don't just want a company that's a one drug wonder," said Cramer. That why the Mad Money host likes this stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.